Influence of long-term physical activity on serum PCSK9, HDL/LDL-cholesterol and lipoprotein a-levels

被引：0

作者：

Sponder, M. ^{[1
]}

Campean, I. A. ^{[1
]}

Dalos, D. ^{[1
]}

Emich, M. ^{[2
]}

Fritzer-Szekeres, M. ^{[3
]}

Litschauer, B. ^{[4
]}

Bergler-Klein, J. ^{[1
]}

Graf, S. ^{[1
]}

Strametz-Juranek, J. ^{[1
]}

机构：

[1] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria

[2] Med Univ Vienna, Fed Minist Def & Sports, Vienna, Austria

[3] Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria

[4] Med Univ Vienna, Clin Pharmacol, Vienna, Austria

来源：

EUROPEAN HEART JOURNAL | 2017年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P1516

引用

页码：315 / 315

页数：1

共 50 条

[41] Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol
Ghosh, Moumita
Gaelman, Cecilia
Rudling, Mats
Angelin, Bo
JOURNAL OF LIPID RESEARCH, 2015, 56 (02) : 463 - 469
[42] Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders
Ruscica, Massimiliano
Simonelli, Sara
Botta, Margherita
Ossoli, Alice
Lupo, Maria Giovanna
Magni, Paolo
Corsini, Alberto
Arca, Marcello
Pisciotta, Livia
Veglia, Fabrizio
Franceschini, Guido
Ferri, Nicola
Calabresi, Laura
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2018, 1863 (09): : 991 - 997
[43] Circulating PCSK9 affects serum LDL and cholesterol levels more than SREBP-2 expression
Mohammadi, Asghar
Shabani, Mohamad
Naseri, Faezeh
Hosseni, Bita
Soltanmohammadi, Elham
Piran, Sadegh
Najafi, Mohammad
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (04): : 655 - 659
[44] Lipoprotein (a) Evolocumab (PCSK9) effectively lowers Lp(a)-, LDL- and ApolipoB Levels
Schulz-Hanke, Ines
AKTUELLE KARDIOLOGIE, 2014, 3 (06) : 340 - 340
[45] Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering
Bandyopadhyay, Dhrubajyoti
Ashish, Kumar
Hajra, Adrija
Qureshi, Arshna
Ghosh, Raktim K.
JOURNAL OF LIPIDS, 2018, 2018
[46] Lack of association between plasma PCSK9 and LDL-cholesterol in patients with controlled type 1 diabetes
Laugier-Robiolle, S.
Verges, B.
Hadjadj, S.
Cariou, B.
DIABETOLOGIA, 2015, 58 : S129 - S129
[47] Fructose Diet Elevates Circulating PCSK9 and LDL-cholesterol Levels and Reduces Liver LDL Receptor Protein Abundance in Hamsters through a Novel Mechanism
Liu, Jingwen
Dong, Bin
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C18 - C18
[48] Fructose Diet Elevates Circulating PCSK9 and LDL-cholesterol Levels and Reduces Liver LDL Receptor Protein Abundance in Hamsters through a Novel Mechanism
Dong, Bin
Singh, Amar B.
Seidah, Nabil G.
Liu, Jingwen
CIRCULATION, 2013, 128 (22)
[49] In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Rothgangl, Tanja
Dennis, Melissa K.
Lin, Paulo J. C.
Oka, Rurika
Witzigmann, Dominik
Villiger, Lukas
Qi, Weihong
Hruzova, Martina
Kissling, Lucas
Lenggenhager, Daniela
Borrelli, Costanza
Egli, Sabina
Frey, Nina
Bakker, Noelle
Walker, John A., II
Kadina, Anastasia P.
Victorov, Denis V.
Pacesa, Martin
Kreutzer, Susanne
Kontarakis, Zacharias
Moor, Andreas
Jinek, Martin
Weissman, Drew
Stoffel, Markus
van Boxtel, Ruben
Holden, Kevin
Pardi, Norbert
Thoeny, Beat
Haeberle, Johannes
Tam, Ying K.
Semple, Sean C.
Schwank, Gerald
NATURE BIOTECHNOLOGY, 2021, 39 (08) : 949 - 957
[50] In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Tanja Rothgangl
Melissa K. Dennis
Paulo J. C. Lin
Rurika Oka
Dominik Witzigmann
Lukas Villiger
Weihong Qi
Martina Hruzova
Lucas Kissling
Daniela Lenggenhager
Costanza Borrelli
Sabina Egli
Nina Frey
Noëlle Bakker
John A. Walker
Anastasia P. Kadina
Denis V. Victorov
Martin Pacesa
Susanne Kreutzer
Zacharias Kontarakis
Andreas Moor
Martin Jinek
Drew Weissman
Markus Stoffel
Ruben van Boxtel
Kevin Holden
Norbert Pardi
Beat Thöny
Johannes Häberle
Ying K. Tam
Sean C. Semple
Gerald Schwank
Nature Biotechnology, 2021, 39 : 949 - 957

← 1 2 3 4 5 →